Five Panel Urine Test: Detection Windows and Cutoff Levels
Lab note: this article was written by AI. People can correct it, but it remains automated, so treat it as general information. Check methods, quantities and safety data against the original sources before you use them in a lab.
The five-panel urine test covers the five drugs or drug classes that laboratories must test for in a U.S. Department of Transportation (DOT) drug test: marijuana, cocaine, amphetamines, opioids and phencyclidine (PCP) [4]. Whether it is for a pre-employment screening, post-accident investigation, or court-ordered monitoring, understanding the analytical thresholds—specifically detection windows and cutoff levels—is essential for interpreting results accurately.
In the field of analytical chemistry, these tests rely on immunoassays to identify specific metabolites. This process of isolating substances within complex mixtures shares fundamental principles with other diagnostic tools, such as the analytical methods for detecting water pollutants, which also utilize precise detection limits to ensure safety and regulatory compliance.
Your reading tools
- SimplifyAny section in plain language
- SummarizeThe key points at a glance
- FAQQuick answers to common questions
- NewSpotted a mistake? We fix it in minutes!
Written with AI from the sources listed at the end.
Table of Contents
- Understanding Cutoff Levels: Screening vs. Confirmation
- Detection Windows: How Long Do Drugs Stay in Your System?
- Factors Affecting Test Accuracy
- Action Plan
- Sources
Understanding Cutoff Levels: Screening vs. Confirmation
In drug testing, a result is not simply “present” or “absent.” Instead, laboratories use “cutoff levels,” measured in nanograms per milliliter (ng/mL), to determine a positive result. Immunoassay cutoffs are designed to eliminate false positives from cross-reacting substances or from trace amounts of a drug or metabolite, such as those found in some foods [1].
The process typically occurs in two stages:
- Initial Screen (Immunoassay): A high-speed, cost-effective test. If the concentration is below the initial cutoff, the result is reported as negative; at or above it, the laboratory must run a confirmation test [4].
- Confirmation Test (GC-MS or LC-MS/MS): If the initial screen is positive, the lab uses Gas Chromatography-Mass Spectrometry (GC/MS) to confirm the specific metabolite. For most drugs this stage uses lower cutoffs (for example 15 instead of 50 ng/mL for the marijuana metabolite), because GC-MS identifies the specific substance, whereas an immunoassay can also react to other compounds [2] [1].
Standard 5-Panel Cutoff Thresholds
According to the Substance Abuse and Mental Health Services Administration (SAMHSA), which publishes the drug testing panel for federal workplace programs, the cutoffs for the five drug classes are as follows [2] (the DOT panel uses the same values, except a morphine confirmation cutoff of 2,000 ng/mL [4]):
| Drug Category | Initial Screen Cutoff | Confirmation Cutoff |
|---|---|---|
| Marijuana (THC) | 50 ng/mL | 15 ng/mL |
| Cocaine | 150 ng/mL | 100 ng/mL |
| Opiates (Codeine/Morphine) | 2000 ng/mL | 2000 ng/mL (codeine), 4000 ng/mL (morphine) |
| Amphetamines | 500 ng/mL | 250 ng/mL |
| Phencyclidine (PCP) | 25 ng/mL | 25 ng/mL |
Note: Federal panels also include hydrocodone/hydromorphone (300 ng/mL initial, 100 ng/mL confirmation), oxycodone/oxymorphone (100/100), 6-acetylmorphine (10/10) and MDMA/MDA (500/250), and since 7 July 2025 the HHS panel for federal agencies also includes fentanyl (1/1, with norfentanyl) [2], which the DOT panel does not [4]. Tests outside federal programs may use other panels and cutoffs.
The initial screening is a fast, cost-effective way to rule out negative samples. If a sample shows a potential positive, a more precise confirmation test like GC-MS is used to eliminate false positives and accurately identify the specific substance.
Cutoff levels, measured in nanograms per milliliter (ng/mL), keep trace amounts of a drug or metabolite, for example from foods, and cross-reacting substances from triggering a positive result.
Not always. For most drugs the confirmation cutoff is lower (for example 15 ng/mL instead of 50 ng/mL for the marijuana metabolite), but for PCP and 6-acetylmorphine it is the same, and in the HHS federal panel the morphine confirmation cutoff (4,000 ng/mL) is higher than the initial codeine/morphine cutoff (2,000 ng/mL).
Detection Windows: How Long Do Drugs Stay in Your System?
The detection window is the timeframe during which a drug metabolite remains at a high enough concentration to trigger a positive result. It depends on the drug, the amount and frequency of use, the person’s metabolic rate, body mass, age and overall health, and urine pH [5].
1. Marijuana (THC)
THC is fat-soluble, so its metabolites are detected in urine for longer than those of other drugs [1].
2. Cocaine
Cocaine is metabolized rapidly into benzoylecgonine.
-
Standard Window: 2–4 days.
-
Heavy Use: Up to 10–22 days in extreme cases [3].
3. Opiates
This panel typically detects heroin, morphine, and codeine.
-
Standard Window: about 2–4 days for codeine, 2–5 days for morphine and 2–3 days for heroin [1].
-
Note: Most opiate immunoassays do not reliably detect oxycodone, oxymorphone, meperidine or fentanyl [5]. Federal panels therefore test hydrocodone, hydromorphone, oxycodone and oxymorphone with their own cutoffs, and the HHS panel for federal agencies has included fentanyl since July 2025 [2]; other tests may need an expanded panel.
4. Amphetamines/Methamphetamines
This panel targets amphetamine and methamphetamine (federal panels also MDMA and MDA) [2], so it detects prescription amphetamines such as Adderall as well as illicit methamphetamine; methylphenidate (Ritalin) is not one of its target drugs.
- Standard Window: about 2–4 days for amphetamine and 2–5 days for methamphetamine [1].
5. Phencyclidine (PCP)
PCP remains part of the federal five-drug panel despite very low use in most settings, so where use is rare a positive PCP screen is likely to be false, for example triggered by dextromethorphan in cough syrups [1].
| Substance | Standard Detection Window |
|---|---|
| Marijuana (THC) | 1–30 days (usage dependent) |
| Cocaine | 2–4 days (Up to 22 for heavy use) |
| Opiates | 2–5 days |
| Amphetamines | 2–4 days |
| PCP | 5–8 days |
THC is fat-soluble and stores in the body’s adipose tissue, leading to a slow release over time. While most drugs clear within a few days, daily marijuana use can be detected for up to about a month.
Not always. Opiate immunoassays detect morphine and codeine (and heroin through its metabolites), but most do not reliably detect oxycodone, oxymorphone, meperidine or fentanyl. Federal panels test oxycodone and related opioids separately, and the HHS panel for federal agencies has included fentanyl since July 2025.
The timeframe depends on the drug’s half-life, the individual’s metabolic rate, their body mass index, and the frequency of use. Chronic or heavy users generally have longer detection windows than one-time users.
Factors Affecting Test Accuracy
The reliability of a five-panel test is high, but several biological and chemical factors can influence the outcome.
-
Hydration and Dilution: Drinking excessive water before a test can lower metabolite concentrations below the cutoff. However, DOT laboratories must measure creatinine on every specimen, and specific gravity when creatinine is below 20 mg/dL, to detect diluted samples [4]; a dilute sample can still test positive, but low levels of other drugs may be missed [1].
-
Body Mass Index (BMI): Body mass is one of the factors that affect detection windows [5]; since THC is fat-soluble, people with more body fat may retain its metabolites longer.
-
Cross-Reactivity (False Positives): Certain legal medications can trigger a preliminary positive. For example, in about 27,400 urine samples from U.S. Navy and Marine Corps members, only about 2% of one immunoassay’s 1,104 amphetamine positives were confirmed, and the decongestant pseudoephedrine was found in 833 of them [7]; in an emergency department, 41% of the amphetamine screens that failed to confirm came from patients prescribed the antidepressant bupropion [6]. Dextromethorphan, found in many cough syrups, can trigger PCP screens [1]. This is why the confirmation (GC-MS) step is vital.
-
Detection Sensitivity: Just as diffuse reflectance spectroscopy is used to analyze surface compositions with high sensitivity, laboratory confirmation by GC-MS identifies each drug or metabolite specifically, instead of reacting to a whole class of compounds as an immunoassay can [1].
While excessive hydration can dilute metabolite concentrations, modern laboratories check for creatinine levels and specific gravity to flag ‘diluted’ samples. A dilute sample is reported as dilute, and it can still test positive.
If a preliminary test is positive due to cross-reactivity with legal medications, the secondary GC-MS confirmation test will accurately identify the substance. You should also disclose your prescriptions to the Medical Review Officer (MRO) to verify legitimate use.
Since fat-soluble substances like THC are stored in body fat, individuals with a higher BMI may retain these metabolites for a longer period than those with lower body fat percentages.
Action Plan
- Review Policy: If you are an employer, ensure your policy matches SAMHSA guidelines or state-specific laws.
- Disclosure: If you are a donor, keep a record of any prescription medications (like ADHD meds or pain management) that could impact results.
- Confirm Results: Never take action based on a “rapid” preliminary test alone; always wait for the lab’s GC-MS confirmation to ensure legal and professional defensibility.
The science of urine drug testing is a balance of analytical precision and practical thresholds, ensuring that workplace safety is maintained without unfairly penalizing individuals for trace environmental exposures.
You should maintain a record of your prescription and be prepared to disclose it to the Medical Review Officer (MRO). This ensures that a positive result for amphetamines can be verified as a legitimate medical use.
No, it is best practice to never take action based on a preliminary ‘rapid’ test alone. To ensure legal and professional defensibility, always wait for the laboratory’s confirmation (GC-MS/LC-MS) result.